New hope for patients with Hard-to-Treat lymphoma?
NCT ID NCT05658562
First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This study tests a new drug called MT-2111 in people with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) that has come back or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink tumors. The trial involves 46 adults in Japan and is in early phases (1 and 2).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aso Iizuka Hospital
Iizuka-shi, Fukuoka, 820-8505, Japan
-
Cancer Institute Hospital of JFCR
Koto-ku, Tokyo, 135-0063, Japan
-
Disaster Medical Center
Tachikawa-shi, Tokyo, 190-0014, Japan
-
Fukushima Medical University Hospital
Fukushima, Fukushima, 960-1295, Japan
-
Gifu Municipal Hospital
Gifu, Gifu, 500-8513, Japan
-
Gunma Prefectural Cancer Center
Ota-shi, Gunma, 373-8550, Japan
-
Hokkaido Cancer Center
Sapporo, Hokkaido, 003-0804, Japan
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Nagoya, Aichi-ken, 466-8650, Japan
-
Japanese Red Cross Nagasaki Genbaku Hospital
Nagasaki, Nagasaki, 852-8104, Japan
-
Japanese Red Cross Society Himeji Hospital
Himeji-shi, Hyōgo, 670-8540, Japan
-
Kanagawa Cancer Center
Yokohama, Kanagawa, 241-8515, Japan
-
Kyushu Cancer Center
Fukuoka, Fukuoka, 811-1395, Japan
-
Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai
Osaka, Osaka, 530-0025, Japan
-
Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
National Cancer Center Hospital
Chuo-ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East
Kashiwa-shi, Chiba, 277-8577, Japan
-
Osaka Saiseikai Nakatsu Hospital
Osaka, Osaka, 530-0012, Japan
-
Shimane University Hospital
Izumo-shi, Shimane, 693-8501, Japan
-
Shinshu University Hospital
Matsumoto-shi, Nagano, 390-8621, Japan
-
Tohoku University Hospital
Sendai, Miyagi, 980-8574, Japan
-
Tokyo Metropolitan Komagome Hospital
Bunkyo-ku, Tokyo, 113-8677, Japan
-
University Hospital, Kyoto Prefectural University of Medicine
Kyoto, Kyoto, 602-8566, Japan
-
Yamagata University Hospital
Yamagata, Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.